Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GIDO (Grupo de Investigación y Divulgación Oncológica) is a Spanish non-profit cooperative group dedicated to clinical and translational research in the field of oncology. Established in 2000, the organization facilitates multicenter clinical trials and scientific studies to improve the diagnosis and treatment of various cancers. The group consists of a multidisciplinary network of oncologists and researchers across Spain, focusing primarily on solid tumors such as lung, breast, and head and neck cancers. GIDO collaborates extensively with the pharmaceutical industry and academic institutions to evaluate new therapeutic agents and optimize existing treatment protocols. In addition to research, the group is heavily involved in the dissemination of scientific knowledge and the continuing education of medical professionals. Their work encompasses the design, implementation, and management of clinical studies aimed at optimizing therapeutic strategies and patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grupo de Investigación y Divulgación Oncológica.